Related Experiment Video
Updated: Jul 31, 2026

4D Imaging of Protein Aggregation in Live Cells
Published on: April 5, 2013
Reversible formation of on-pathway macroscopic aggregates during the folding of maltose binding protein
C Ganesh1, F N Zaidi, J B Udgaonkar
1Molecular Biophysics Unit, Indian Institute of Science, Bangalore 560 012, India.
Abstract:
Maltose binding protein (MBP) is widely used as a model for protein folding and export studies. We show here that macroscopic aggregates form transiently during the refolding of MBP at micromolar protein concentrations. Disaggregation occurs spontaneously without any aid, and the refolded material has structure and activity identical to those of the native, nondenatured protein. A considerable fraction of protein undergoing folding partitions into the aggregate phase and can be manually separated from the soluble phase by centrifugation. The separated MBP precipitate can be resolubilized and yields active, refolded protein. This demonstrates that both the soluble and aggregate phases contribute to the final yield of refolded protein. SecB, the cognate Escherichia coli cytosolic chaperone in vivo for MBP, reduces but does not entirely prevent aggregation, whereas GroEL and a variety of other control proteins have no effect. Kinetic studies using a variety of spectroscopic probes show that aggregation occurs through a collapsed intermediate with some secondary structure. The aggregate formed during refolding can convert directly to a near native state without going through the unfolded state. Further, optical and electron microscopic studies indicate that the MBP precipitate is not an amyloid.
Insights
During maltose binding protein (MBP) refolding, transient aggregates form and spontaneously disaggregate. These aggregates yield active protein, contributing to overall refolding efficiency.
Area of Science:
- Biochemistry
- Protein Folding
- Molecular Biology
Background:
- Maltose binding protein (MBP) is a crucial model for studying protein folding and export mechanisms.
- Understanding protein aggregation during refolding is vital for protein therapeutics and biotechnology.
Purpose of the Study:
- To investigate the transient formation and spontaneous disaggregation of macroscopic aggregates during maltose binding protein (MBP) refolding.
- To characterize the nature of these aggregates and their contribution to the final yield of active protein.
Main Methods:
- Micromolar concentrations of MBP were refolded, and aggregate formation was monitored.
- Centrifugation was used to separate soluble and aggregated protein phases.
- Spectroscopic probes (optical and electron microscopy) were employed to analyze aggregate structure and kinetics.
- The effect of chaperones like SecB and GroEL on aggregation was assessed.
Main Results:
- Macroscopic aggregates form transiently during MBP refolding at micromolar concentrations.
- These aggregates spontaneously disaggregate, yielding refolded protein with native structure and activity.
- Both soluble and aggregated phases contribute to the total refolded protein yield.
- SecB chaperone reduced but did not eliminate aggregation; GroEL had no effect.
- Aggregation proceeds via a collapsed intermediate with secondary structure; aggregates can convert directly to a native state.
- MBP aggregates are not amyloid structures.
Conclusions:
- Transient aggregation during MBP refolding is a reversible process that contributes to the overall yield of active protein.
- Chaperone interactions, specifically with SecB, can modulate but not abolish this aggregation pathway.
- The findings provide insights into protein folding dynamics and strategies for optimizing recombinant protein production.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Molecular Chaperones and Protein Folding
The...
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Protein Folding Quality Check in the RER
Export of Misfolded Proteins out of the ER
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

